BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33354869)

  • 1. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings.
    Ti L; Tobias S; Maghsoudi N; Milloy MJ; McDonald K; Shapiro A; Beriault D; Stefan C; Lysyshyn M; Werb D
    Drug Alcohol Rev; 2021 May; 40(4):580-585. PubMed ID: 33354869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of Synthetic Cannabinoid New Psychoactive Substances 4F-MDMB-BUTINACA and MDMB-4en-PINACA].
    Wang KD; Yuan XL; Zhang YR; Hu JJ; Cao FQ; Chen YS
    Fa Yi Xue Za Zhi; 2021 Aug; 37(4):505-510. PubMed ID: 34726003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.
    Crepeault H; Socias ME; Tobias S; Lysyshyn M; Custance A; Shapiro A; Ti L
    Drug Alcohol Rev; 2023 Mar; 42(3):538-543. PubMed ID: 36423900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
    Liu C; Jia W; Hua Z; Qian Z
    Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019-April 2020.
    Scarfone KM; Maghsoudi N; McDonald K; Stefan C; Beriault DR; Wong E; Evert M; Hopkins S; Leslie P; Watson TM; Werb D;
    Harm Reduct J; 2022 Jan; 19(1):3. PubMed ID: 35012557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
    Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
    Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a simultaneous screening method for the detection of new psychoactive substances in various matrix samples using liquid chromatography/electrospray ionization tandem mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Kim NS; Lim NY; Choi HS; Lee JH; Kim H; Baek SY
    Rapid Commun Mass Spectrom; 2021 May; 35(10):e9067. PubMed ID: 33656207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
    Krotulski AJ; Mohr ALA; Logan BK
    J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada.
    Scarfone KM; Maghsoudi N; McDonald K; Thompson H; Stefan C; Beriault DR; Werb D; Bowles JM
    Clin Toxicol (Phila); 2022 Aug; 60(8):979-984. PubMed ID: 35546568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthetic cannabinoid 5F-MDMB-PICA: A case series.
    Kleis J; Germerott T; Halter S; Héroux V; Roehrich J; Schwarz CS; Hess C
    Forensic Sci Int; 2020 Sep; 314():110410. PubMed ID: 32683270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
    Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
    Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GC-MS Identification and Quantification of the Synthetic Cannabinoid MDMB-4en- PINACA in Cannabis-derived Material Seized in the Turin Metropolitan Area (Italy).
    Gerace E; Seganti F; Di Corcia D; Vincenti M; Salomone A
    Curr Pharm Des; 2022; 28(32):2618-2621. PubMed ID: 35658890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
    Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
    Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
    Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
    Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harms.
    Ralphs R; Gray P; Sutcliffe OB
    Int J Drug Policy; 2021 Nov; 97():103305. PubMed ID: 34146792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
    Gatch MB; Forster MJ
    Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.